Cleared Traditional

K072049 - CONTINUOUS NON-INVASIVE CARDIAC OUTPUT AND BLOOD PRESSURE MONITOR WITH REAL-TIME HEMODYNAMICS

K072049 is an FDA 510(k) clearance for CONTINUOUS NON-INVASIVE CARDIAC OUTPUT ..., manufactured by Bmeye B.V.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 127-day FDA review.

K072049 · Bmeye B.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
127d
Days
Class 2
Risk

K072049 is an FDA 510(k) clearance for the CONTINUOUS NON-INVASIVE CARDIAC OUTPUT AND BLOOD PRESSURE MONITOR WITH REAL-T.... Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Bmeye B.V. (Westford, US). The FDA issued a Cleared decision on November 29, 2007 after a review of 127 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bmeye B.V. devices

FDA 510(k) Submission Details - K072049

510(k) Number K072049 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2007
Decision Date November 29, 2007
Days to Decision 127 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 125d · This submission: 127d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 901
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K072049.
MICROLIFE UPPER ARM MANUAL BLOOD PRESSURE MONITOR, MODEL BP3MR1-H (BP A50)
K073397 · Microlife Corp. · Dec 2007
MICROLIFE WRIST WATCH BLOOD PRESSURE MONITOR, MODEL BP3MK1-3 (BP W100)
K073398 · Microlife Corp. · Dec 2007
AVITA BLUETOOTH BLOOD PRESSURE MONITOR, MODEL: BPM656ZB
K072137 · Avita Corporation · Dec 2007
MOBIL-O-GRAPH NG 24 H ABP-CONTROL
K072446 · I.E.M. GmbH · Nov 2007
A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS SYSTEM AND PC SOFTWARE
K072593 · Healthstats International Pte. , Ltd. · Nov 2007
MODIFICATION TO: DIGITAL BLOOD PRESSURE MONITOR, MODEL 1901
K071384 · Nihon Seimitsu Sokki Co., Ltd. · Oct 2007